Innoviva Inc
NASDAQ:INVA

Watchlist Manager
Innoviva Inc Logo
Innoviva Inc
NASDAQ:INVA
Watchlist
Price: 19.3 USD -3.5% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Innoviva Inc?
Write Note

Innoviva Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innoviva Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Innoviva Inc
NASDAQ:INVA
Gross Profit
$310.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Gross Profit
$60.7B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$36B
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
12%
Pfizer Inc
NYSE:PFE
Gross Profit
$42.6B
CAGR 3-Years
-2%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$48.4B
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$33.1B
CAGR 3-Years
17%
CAGR 5-Years
14%
CAGR 10-Years
8%

See Also

What is Innoviva Inc's Gross Profit?
Gross Profit
310.2m USD

Based on the financial report for Sep 30, 2024, Innoviva Inc's Gross Profit amounts to 310.2m USD.

What is Innoviva Inc's Gross Profit growth rate?
Gross Profit CAGR 1Y
24%

Over the last year, the Gross Profit growth was 24%.

Back to Top